Urban mouse allergens worsen childhood asthma risks
Featured

Urban mouse allergens worsen childhood asthma risks

Clinic Moves

People with disabilities face higher substance misuse risk
Clinic Moves
November 5, 2026

People with disabilities face higher substance misuse risk

People with disabilities may face higher substance misuse risk due to chronic pain and multiple...

Researchers study synthetic growth hormone stimulator
Clinic Moves
November 4, 2026

Researchers study synthetic growth hormone stimulator

Researchers study synthetic growth hormone stimulator to understand its effects on growth hormone secretion.

Immunotherapy Rewrites Melanoma Lymph Node Environment
Clinic Moves
October 31, 2026

Immunotherapy Rewrites Melanoma Lymph Node Environment

Checkpoint immunotherapy may reshape melanoma-involved lymph nodes, reorganizing cell types and altering macrophage behavior, Mayo...

Drug Approvals

Read our latest Drug Approvals articles.

Mayo Clinic Develops Real-Time Airborne Pathogen Detection System
Drug Approvals October 26, 2026

Mayo Clinic Develops Real-Time Airborne Pathogen Detection System

Mayo Clinic develops a real-time airborne pathogen detection system that could transform indoor biological threat...

Breast cancer screening becomes more personalized with risk-based guidelines
Drug Approvals October 25, 2026

Breast cancer screening becomes more personalized with risk-based guidelines

Personalized breast cancer screening guidelines are replacing one-size-fits-all approaches, offering tailored plans based on individual...

Outbreak Watch

Trial Briefs

All Posts

Dermatology Society Urges New Tests for Stubborn Eczema
Trial Briefs

Dermatology Society Urges New Tests for Stubborn Eczema

Stubborn eczema may signal hidden conditions, so the American Academy of Dermatology now urges doctors to run new tests before...

New AAN AHS Guideline Recommends Adult Migraine Prevention
Trial Briefs

New AAN AHS Guideline Recommends Adult Migraine Prevention

The new American Association of Neurology and American Headache Society guideline outlines migraine preventive pharmacologic treatment for adults,.

Early Kidney Disease Diagnosis Rates Stagnant
Trial Briefs

Early Kidney Disease Diagnosis Rates Stagnant

Early kidney disease diagnosis rates remain stagnant despite increased screening, highlighting challenges in healthcare detection.

Vonoprazan Eases Nighttime Symptoms in NERD Patients
Drug Approvals

Vonoprazan Eases Nighttime Symptoms in NERD Patients

Vonoprazan significantly reduces nighttime reflux symptoms in patients with NERD, offering a promising new treatment option for better sleep.

Diagnostic guidelines for suspected epilepsy take shape
Vaccine News

Diagnostic guidelines for suspected epilepsy take shape

New diagnostic guidelines for suspected epilepsy focus on ruling out seizures and classifying focal or generalized types—experts emphasize patient history...

Zorevunersen Shows Adaptive Gains in Dravet Patients
Clinic Moves

Zorevunersen Shows Adaptive Gains in Dravet Patients

Zorevunersen dravet patients showed adaptive gains over two years, surpassing standard antiseizure therapy in a study at the Epilepsy Congress.

Valbenazine Improves Quality of Life in Tardive Dyskinesia
Trial Briefs

Valbenazine Improves Quality of Life in Tardive Dyskinesia

New study finds valbenazine significantly improves quality of life for adults with tardive dyskinesia.

Dual Therapy Shifts SMA Treatment Landscape
Trial Briefs

Dual Therapy Shifts SMA Treatment Landscape

Discover how dual therapy is reshaping spinal muscular atrophy treatment as experts debate combining treatments to improve SMA patient outcomes.

Neurology and Headache Societies Release New Migraine Guideline
Trial Briefs

Neurology and Headache Societies Release New Migraine Guideline

The American Academy of Neurology and American Headache Society released an updated migraine prevention guideline for adults, replacing the 2012.

Combined Risk Factors Linked to Late Parkinson Disease
Trial Briefs

Combined Risk Factors Linked to Late Parkinson Disease

Study reveals combined risk factors significantly increase late-onset Parkinson disease risk, with multiple exposures showing synergistic effects beyond individ

Show More →